Trial intelligence / Profile preview

Gardasil in HIV-infected young women

NCT00710593Phase 2Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Feb 2008
Primary completion
Feb 2011
Modality
Vaccines & Immunotherapeutics
Countries
2
01

Overview

A Phase 2 trial of qHPV vaccine in human papillomavirus infection, sponsored by University of North Carolina at Chapel Hill. Started Feb 2008; status: completed.

02

Drugs

qHPV vaccine
03

Conditions

human papillomavirus infection

Beyond the preview

Go deeper on NCT00710593.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00710593.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call